Drug Profile
Research programme: antibody drug conjugate - Bliss Biopharmaceutical
Alternative Names: monoclonal antibody-eribulin conjugateLatest Information Update: 14 Jun 2022
Price :
$50
*
At a glance
- Originator Bliss Biopharmaceutical
- Developer Bliss Biopharmaceutical; Morphotek
- Class 2 ring heterocyclic compounds; Antineoplastics; Cyclic ethers; Drug conjugates; Furans; Immunotoxins; Ketones; Macrocyclic compounds; Monoclonal antibodies
- Mechanism of Action Apoptosis stimulants; Receptor protein-tyrosine kinase modulators; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer